Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) is considered safe and effective. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.